ITCMDBv1
Clinical TrialID 1603

Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants

NCT02092857

Focus: Nutritional Requirements for Infants

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
1603
Evidence Id
1603
Core Evidence Id
1603
Source Clinical Trial Id
1577
Herb2 Clinical Trial Id
HBCT001577
Nct Id
NCT02092857
Title
Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants
Status
Completed
Phase
Phase 1
Study Result
Yes
Study Condition
Focus: Nutritional Requirements for Infants
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Intervention
DIETARY_SUPPLEMENT: Arachidonic acid (25 mg/100 kcal )|DIETARY_SUPPLEMENT: Arachidonic acid (34 mg/100 kcal)|DIETARY_SUPPLEMENT: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Basic_Science
Gender
All
Age
Child
Enrollment
89
Outcome Measure
Number of Antigen-presenting B Cells, 10 weeks
Sponsor Collaborator
University of Alberta|Mead Johnson Nutrition
Funded By
OTHER
Location
University of Alberta Hospital, Edmonton, Alberta, T6G 2B7, Canada
Other Id
Pro00005583|230831
Start Date
2009-12
Primary Completion Date
2013-11
Completion Date
2014-02
First Posted
2014-03-20
Results First Posted
2014-04-25
Last Update Posted
2014-04-25
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02092857
Title Cn
Title En
Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants
Bilingual Status
semi_complete